| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2023 | Valko Z, Megyesfalvi Z, Schwendenwein A, Lang C, Paku S, Barany N, Ferencz B, Horvath-Rozsas A, Kovacs I, Schlegl E, Pozonec V, Boettiger K, Rezeli M, Marko-Varga G, Renyi-Vamos F, et al. Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer. British Journal of Cancer. PMID 36918717 DOI: 10.1038/s41416-023-02219-9 | 0.599 | |||
| 2022 | Szeitz B, Megyesfalvi Z, Woldmar N, Valkó Z, Schwendenwein A, Bárány N, Paku S, László V, Kiss H, Bugyik E, Lang C, Szász AM, Pizzatti L, Bogos K, Hoda MA, et al. In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer. Clinical and Translational Medicine. 12: e1060. PMID 36149789 DOI: 10.1002/ctm2.1060 | 0.614 | |||
| 2022 | Kovacs I, Bugyik E, Dezso K, Tarnoki-Zach J, Mehes E, Gulyas M, Czirok A, Lang E, Grusch M, Schelch K, Hegedus B, Horvath I, Barany N, Megyesfalvi Z, Tisza A, ... ... Paku S, et al. Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow. Translational Lung Cancer Research. 11: 991-1008. PMID 35832452 DOI: 10.21037/tlcr-21-828 | 0.575 | |||
| 2022 | Megyesfalvi Z, Barany N, Lantos A, Valko Z, Pipek O, Lang C, Schwendenwein A, Oberndorfer F, Paku S, Ferencz B, Dezso K, Fillinger J, Lohinai Z, Moldvay J, Galffy G, et al. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer: an international multicenter study. The Journal of Pathology. PMID 35489038 DOI: 10.1002/path.5922 | 0.606 | |||
| 2021 | Barany N, Rozsas A, Megyesfalvi Z, Grusch M, Hegedus B, Lang C, Boettiger K, Schwendenwein A, Tisza A, Renyi-Vamos F, Schelch K, Hoetzenecker K, Hoda MA, Paku S, Laszlo V, et al. Clinical relevance of circulating activin A and follistatin in small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 161: 128-135. PMID 34583221 DOI: 10.1016/j.lungcan.2021.09.008 | 0.604 | |||
| 2021 | Schwendenwein A, Megyesfalvi Z, Barany N, Valko Z, Bugyik E, Lang C, Ferencz B, Paku S, Lantos A, Fillinger J, Rezeli M, Marko-Varga G, Bogos K, Galffy G, Renyi-Vamos F, et al. Molecular profiles of small cell lung cancer subtypes: therapeutic implications. Molecular Therapy Oncolytics. 20: 470-483. PMID 33718595 DOI: 10.1016/j.omto.2021.02.004 | 0.609 | |||
| 2021 | Berta J, Török S, Tárnoki-Zách J, Drozdovszky O, Tóvári J, Paku S, Kovács I, Czirók A, Masri B, Megyesfalvi Z, Oskolás H, Malm J, Ingvar C, Markó-Varga G, Döme B, et al. Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis. Scientific Reports. 11: 5798. PMID 33707612 DOI: 10.1038/s41598-021-85162-0 | 0.638 | |||
| 2020 | Megyesfalvi Z, Bárány N, Valkó Z, Bugyik E, Paku S, Berta J, Lantos A, Fillinger J, Moldvay J, Bogos K, Rezeli M, Gálffy G, Lang C, Lohinai Z, Hécz R, et al. [Heterogeneity of small cell lung cancer: biological and clinicopathological implications]. Magyar Onkologia. 64: 243-255. PMID 34608895 | 0.629 | |||
| 2020 | Szücs A, Paku S, Sebestyén E, Nagy P, Dezső K. Postnatal, ontogenic liver growth accomplished by biliary/oval cell proliferation and differentiation. Plos One. 15: e0233736. PMID 32470002 DOI: 10.1371/Journal.Pone.0233736 | 0.375 | |||
| 2019 | Dezső K, Nagy P, Paku S. Human liver regeneration following massive hepatic necrosis - two distinct patterns. Journal of Gastroenterology and Hepatology. PMID 31090096 DOI: 10.1111/Jgh.14721 | 0.328 | |||
| 2019 | Téglási V, Csűry DT, Dezső K, Bugyik E, Szabó V, Szállási Z, Paku S, Reiniger L. Origin and Distribution of Connective Tissue and Pericytes Impacting Vascularization in Brain Metastases With Different Growth Patterns. Journal of Neuropathology and Experimental Neurology. PMID 30816955 DOI: 10.1093/Jnen/Nlz007 | 0.369 | |||
| 2018 | Bugyik E, Szabó V, Dezső K, Rókusz A, Szücs A, Nagy P, Tóvári J, László V, Döme B, Paku S. Role of (myo)fibroblasts in the development of vascular and connective tissue structure of the C38 colorectal cancer in mice. Cancer Communications (London, England). 38: 46. PMID 29976246 DOI: 10.1186/S40880-018-0316-X | 0.623 | |||
| 2017 | Dezső K, Rókusz A, Bugyik E, Szücs A, Szuák A, Dorogi B, Kiss M, Nemeskéri Á, Nagy P, Paku S. Erratum to "Human liver regeneration in advanced cirrhosis is organized by the portal tree" [J Hepatol 66 (2017) 778-786]. Journal of Hepatology. 67: 430-436. PMID 28716380 DOI: 10.1016/J.Jhep.2017.05.018 | 0.308 | |||
| 2017 | Tátrai E, Bartal A, Gacs A, Paku S, Kenessey I, Garay T, Hegedűs B, Molnár E, Cserepes MT, Hegedűs Z, Kucsma N, Szakács G, Tóvári J. Cell type-dependent HIF1 α-mediated effects of hypoxia on proliferation, migration and metastatic potential of human tumor cells. Oncotarget. PMID 28562340 DOI: 10.18632/Oncotarget.17806 | 0.427 | |||
| 2017 | Torok S, Rezeli M, Kelemen O, Vegvari A, Watanabe K, Sugihara Y, Tisza A, Marton T, Kovacs I, Tovari J, Laszlo V, Helbich TH, Hegedus B, Klikovits T, Hoda MA, ... ... Paku S, et al. Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors. Theranostics. 7: 400-412. PMID 28042343 DOI: 10.7150/Thno.16767 | 0.639 | |||
| 2016 | Paku S, Laszlo V, Dezso K, Nagy P, Hoda MA, Klepetko W, Renyi-Vamos F, Timar J, Reynolds AR, Dome B. The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis and endothelialisation. The Journal of Pathology. PMID 28026875 DOI: 10.1002/Path.4855 | 0.646 | |||
| 2016 | Rókusz A, Bugyik E, Szabó V, Szücs A, Paku S, Nagy P, Dezső K. Imatinib accelerates progenitor cell-mediated liver regeneration in choline-deficient ethionine-supplemented diet-fed mice. International Journal of Experimental Pathology. PMID 27918111 DOI: 10.1111/Iep.12209 | 0.353 | |||
| 2016 | Dezső K, Rókusz A, Bugyik E, Szücs A, Szuák A, Dorogi B, Kiss M, Nemeskéri Á, Nagy P, Paku S. Human liver regeneration in advanced cirrhosis is organized by the portal tree. Journal of Hepatology. PMID 27913222 DOI: 10.1016/J.Jhep.2016.11.014 | 0.342 | |||
| 2016 | Bridgeman VL, Vermeulen PB, Foo S, Bilecz A, Daley F, Kostaras E, Nathan MR, Wan E, Frentzas S, Schweiger T, Hegedus B, Hoetzenecker K, Renyi-Vamos F, Kuczynski EA, Vasudev NS, ... ... Paku S, et al. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models. The Journal of Pathology. PMID 27859259 DOI: 10.1002/Path.4845 | 0.404 | |||
| 2016 | Bugyik E, Renyi-Vamos F, Szabo V, Dezso K, Ecker N, Rokusz A, Nagy P, Dome B, Paku S. Mechanisms of vascularization in murine models of primary and metastatic tumor growth. Chinese Journal of Cancer. 35: 19. PMID 26873579 DOI: 10.1186/S40880-016-0083-5 | 0.391 | |||
| 2015 | Szabó V, Bugyik E, Dezsõ K, Tóvári J, Döme B, Paku S. [Role of tumour cell invasion/migration in the vascularisation of experimental lung metastases]. Magyar Onkologia. 59: 319-23. PMID 26665192 | 0.304 | |||
| 2015 | Hajósi-Kalcakosz S, Vincze E, Dezső K, Paku S, Rókusz A, Sápi Z, Tóth E, Nagy P. EZH2 is a sensitive marker of malignancy in salivary gland tumors. Diagnostic Pathology. 10: 163. PMID 26377323 DOI: 10.1186/S13000-015-0392-Z | 0.313 | |||
| 2015 | Fülöp A, Budai A, Czigány Z, Lotz G, Dezső K, Paku S, Harsányi L, Szijártó A. Alterations in hepatic lobar function in regenerating rat liver. The Journal of Surgical Research. 197: 307-17. PMID 25963167 DOI: 10.1016/J.Jss.2015.04.033 | 0.316 | |||
| 2015 | Fullár A, Dudás J, Oláh L, Hollósi P, Papp Z, Sobel G, Karászi K, Paku S, Baghy K, Kovalszky I. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. Bmc Cancer. 15: 256. PMID 25885552 DOI: 10.1186/S12885-015-1272-3 | 0.363 | |||
| 2015 | Torok S, Vegvari A, Rezeli M, Fehniger TE, Tovari J, Paku S, Laszlo V, Hegedus B, Rozsas A, Dome B, Marko-Varga G. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study. British Journal of Pharmacology. 172: 1148-63. PMID 25363319 DOI: 10.1111/Bph.12990 | 0.574 | |||
| 2015 | Szabo V, Bugyik E, Dezso K, Ecker N, Nagy P, Timar J, Tovari J, Laszlo V, Bridgeman VL, Wan E, Frentzas S, Vermeulen PB, Reynolds AR, Dome B, Paku S. Mechanism of tumour vascularization in experimental lung metastases. The Journal of Pathology. 235: 384-96. PMID 25319725 DOI: 10.1002/Path.4464 | 0.648 | |||
| 2014 | Tóvári J, Futosi K, Bartal A, Tátrai E, Gacs A, Kenessey I, Paku S. Boyden chamber-based method for characterizing the distribution of adhesions and cytoskeletal structure in HT1080 fibrosarcoma cells. Cell Adhesion & Migration. 8: 509-16. PMID 25482525 DOI: 10.4161/Cam.28734 | 0.322 | |||
| 2014 | Berta J, Hoda MA, Laszlo V, Rozsas A, Garay T, Torok S, Grusch M, Berger W, Paku S, Renyi-Vamos F, Masri B, Tovari J, Groger M, Klepetko W, Hegedus B, et al. Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget. 5: 4426-37. PMID 24962866 DOI: 10.18632/Oncotarget.2032 | 0.645 | |||
| 2014 | Papp V, Rókusz A, Dezső K, Bugyik E, Szabó V, Pávai Z, Paku S, Nagy P. Expansion of hepatic stem cell compartment boosts liver regeneration. Stem Cells and Development. 23: 56-65. PMID 23952741 DOI: 10.1089/Scd.2013.0202 | 0.383 | |||
| 2014 | Tátrai E, Bartal A, Fehér Z, Farkas Á, Paku S, Kenessey I, Tóvári J. Abstract 4965: Hypoxia has different effects on proliferation, migration and metastasis of various types of tumor cells Cancer Research. 74: 4965-4965. DOI: 10.1158/1538-7445.Am2014-4965 | 0.414 | |||
| 2012 | Hajósi-Kalcakosz S, Dezső K, Bugyik E, Bödör C, Paku S, Pávai Z, Halász J, Schlachter K, Schaff Z, Nagy P. Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors. Diagnostic Pathology. 7: 86. PMID 22809481 DOI: 10.1186/1746-1596-7-86 | 0.361 | |||
| 2012 | Péterfia B, Füle T, Baghy K, Szabadkai K, Fullár A, Dobos K, Zong F, Dobra K, Hollósi P, Jeney A, Paku S, Kovalszky I. Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2. Plos One. 7: e39474. PMID 22745764 DOI: 10.1371/Journal.Pone.0039474 | 0.399 | |||
| 2012 | Dezső K, Papp V, Bugyik E, Hegyesi H, Sáfrány G, Bödör C, Nagy P, Paku S. Structural analysis of oval-cell-mediated liver regeneration in rats. Hepatology (Baltimore, Md.). 56: 1457-67. PMID 22419534 DOI: 10.1002/Hep.25713 | 0.386 | |||
| 2012 | Bugyik E, Dezso K, Turányi E, Szurián K, Paku S, Nagy P. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene induces substantial hyperplasia in fibrotic mouse liver. International Journal of Experimental Pathology. 93: 125-9. PMID 22243368 DOI: 10.1111/J.1365-2613.2011.00803.X | 0.356 | |||
| 2011 | Bugyik E, Dezso K, Reiniger L, László V, Tóvári J, Tímár J, Nagy P, Klepetko W, Döme B, Paku S. Lack of angiogenesis in experimental brain metastases. Journal of Neuropathology and Experimental Neurology. 70: 979-91. PMID 22002424 DOI: 10.1097/Nen.0B013E318233Afd7 | 0.66 | |||
| 2011 | Paku S, Dezso K, Bugyik E, Tóvári J, Tímár J, Nagy P, Laszlo V, Klepetko W, Döme B. A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sprouting. The American Journal of Pathology. 179: 1573-85. PMID 21827961 DOI: 10.1016/J.Ajpath.2011.05.033 | 0.631 | |||
| 2011 | Baghy K, Dezso K, László V, Fullár A, Péterfia B, Paku S, Nagy P, Schaff Z, Iozzo RV, Kovalszky I. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 439-51. PMID 20956977 DOI: 10.1038/Labinvest.2010.172 | 0.624 | |||
| 2010 | Berta J, Kenessey I, Dobos J, Tovari J, Klepetko W, Jan Ankersmit H, Hegedus B, Renyi-Vamos F, Varga J, Lorincz Z, Paku S, Ostoros G, Rozsas A, Timar J, Dome B. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1120-9. PMID 20581707 DOI: 10.1097/Jto.0B013E3181E2C1Ff | 0.438 | |||
| 2009 | Turányi E, Dezso K, Paku S, Nagy P. DLK is a novel immunohistochemical marker for adrenal gland tumors. Virchows Archiv : An International Journal of Pathology. 455: 295-9. PMID 19685073 DOI: 10.1007/S00428-009-0819-6 | 0.34 | |||
| 2009 | Dezso K, Bugyik E, Papp V, László V, Döme B, Tóvári J, Tímár J, Nagy P, Paku S. Development of arterial blood supply in experimental liver metastases. The American Journal of Pathology. 175: 835-43. PMID 19574433 DOI: 10.2353/Ajpath.2009.090095 | 0.626 | |||
| 2009 | Dezso K, Paku S, Papp V, Turányi E, Nagy P. Architectural and immunohistochemical characterization of biliary ductules in normal human liver. Stem Cells and Development. 18: 1417-22. PMID 19552603 DOI: 10.1089/Scd.2009.0110 | 0.358 | |||
| 2009 | Papp V, Dezsö K, László V, Nagy P, Paku S. Architectural changes during regenerative and ontogenic liver growth in the rat. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 15: 177-83. PMID 19177433 DOI: 10.1002/Lt.21665 | 0.611 | |||
| 2009 | Dome B, Timar J, Ladanyi A, Paku S, Renyi-Vamos F, Klepetko W, Lang G, Dome P, Bogos K, Tovari J. Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapy. Critical Reviews in Oncology/Hematology. 69: 108-24. PMID 18768327 DOI: 10.1016/J.Critrevonc.2008.06.009 | 0.409 | |||
| 2008 | Kóbori L, Nagy P, Máthé Z, Hartmann E, Doros A, Paku S, Dezso K, Sápi Z. Malignant peripheral nerve sheath tumor of the liver: a case report. Pathology Oncology Research : Por. 14: 329-32. PMID 18758998 DOI: 10.1007/S12253-008-9078-0 | 0.332 | |||
| 2008 | László V, Dezso K, Baghy K, Papp V, Kovalszky I, Sáfrány G, Thorgeirsson SS, Nagy P, Paku S. Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes. Histochemistry and Cell Biology. 130: 1005-14. PMID 18663461 DOI: 10.1007/S00418-008-0482-Z | 0.639 | |||
| 2008 | Dezso K, Halász J, Bisgaard HC, Paku S, Turányi E, Schaff Z, Nagy P. Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas. Virchows Archiv : An International Journal of Pathology. 452: 443-8. PMID 18236070 DOI: 10.1007/S00428-007-0571-8 | 0.357 | |||
| 2008 | Dome B, Dobos J, Tovari J, Paku S, Kovacs G, Ostoros G, Timar J. Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 73: 186-93. PMID 18000872 DOI: 10.1002/Cyto.A.20480 | 0.401 | |||
| 2007 | Dezso K, Jelnes P, László V, Baghy K, Bödör C, Paku S, Tygstrup N, Bisgaard HC, Nagy P. Thy-1 is expressed in hepatic myofibroblasts and not oval cells in stem cell-mediated liver regeneration. The American Journal of Pathology. 171: 1529-37. PMID 17884967 DOI: 10.2353/Ajpath.2007.070273 | 0.645 | |||
| 2007 | Végso G, Sebestyén A, Paku S, Barna G, Hajdu M, Tóth M, Járay J, Kopper L. Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas. Leukemia Research. 31: 1003-8. PMID 17320952 DOI: 10.1016/J.Leukres.2006.12.019 | 0.362 | |||
| 2007 | Döme B, Hendrix MJ, Paku S, Tóvári J, Tímár J. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. The American Journal of Pathology. 170: 1-15. PMID 17200177 DOI: 10.2353/Ajpath.2007.060302 | 0.42 | |||
| 2006 | Péterfia B, Hollósi P, Szilák L, Timár F, Paku S, Jeney A, Kovalszky I. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma]. Magyar Onkologia. 50: 115-20. PMID 16888674 | 0.311 | |||
| 2006 | Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Research. 66: 7341-7. PMID 16849585 DOI: 10.1158/0008-5472.Can-05-4654 | 0.35 | |||
| 2005 | Tokés AM, Kulka J, Paku S, Máthé M, Páska C, Lódi C, Kiss A, Schaff Z. The expression of five different claudins in invasive breast carcinomas: comparison of pT1pN1 and pT1pN0 tumors. Pathology, Research and Practice. 201: 537-44. PMID 16259105 DOI: 10.1016/J.Prp.2005.05.005 | 0.371 | |||
| 2005 | Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7344-53. PMID 16243806 DOI: 10.1158/1078-0432.Ccr-05-1077 | 0.39 | |||
| 2005 | Tóvári J, Gilly R, Rásó E, Paku S, Bereczky B, Varga N, Vágó A, Tímár J. Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models. Cancer Research. 65: 7186-93. PMID 16103069 DOI: 10.1158/0008-5472.Can-04-2498 | 0.435 | |||
| 2005 | Raffai G, Fehér E, Nádasy G, Paku S, Pogány G, Tímár F, Szende B, Monos E. Selective suppression of an endothelin and platelet-derived growth factor containing vesicular system in endothelium of rat saphenous vein by long-term orthostasis. Journal of Vascular Research. 42: 157-64. PMID 15767762 DOI: 10.1159/000084404 | 0.311 | |||
| 2005 | Paku S, Kopper L, Nagy P. Development of the vasculature in "pushing-type" liver metastases of an experimental colorectal cancer. International Journal of Cancer. 115: 893-902. PMID 15729725 DOI: 10.1002/Ijc.20886 | 0.342 | |||
| 2004 | Forster-Horváth C, Döme B, Paku S, Ladányi A, Somlai B, Jalkanen S, Tímár J. Loss of vascular adhesion protein-1 expression in intratumoral microvessels of human skin melanoma. Melanoma Research. 14: 135-40. PMID 15057044 DOI: 10.1097/00008390-200404000-00010 | 0.356 | |||
| 2003 | Paku S, Tóvári J, Lörincz Z, Timár F, Döme B, Kopper L, Raz A, Tímár J. Adhesion dynamics and cytoskeletal structure of gliding human fibrosarcoma cells: a hypothetical model of cell migration. Experimental Cell Research. 290: 246-53. PMID 14567984 DOI: 10.1016/S0014-4827(03)00334-3 | 0.35 | |||
| 2003 | Rásó E, Paku S, Kopper L, Tímár J. Trace elements improve survival of DTIC-treated mice with overt liver metastases of Lewis lung carcinoma. Pathology Oncology Research : Por. 9: 96-9. PMID 12858213 DOI: 10.1007/Bf03033751 | 0.332 | |||
| 2003 | Döme B, Tímár J, Paku S. A novel concept of glomeruloid body formation in experimental cerebral metastases. Journal of Neuropathology and Experimental Neurology. 62: 655-61. PMID 12834110 DOI: 10.1093/Jnen/62.6.655 | 0.407 | |||
| 2002 | Döme B, Paku S, Somlai B, Tímár J. Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance. The Journal of Pathology. 197: 355-62. PMID 12115882 DOI: 10.1002/Path.1124 | 0.372 | |||
| 2001 | Tímár J, Döme B, Fazekas K, Janovics Á, Paku S. Angiogenesis-dependent diseases and angiogenesis therapy. Pathology & Oncology Research. 7: 85-94. PMID 11458270 DOI: 10.1007/Bf03032573 | 0.353 | |||
| 2001 | Lukits J, Timár J, Juhász A, Döme B, Paku S, Répássy G. Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 125: 18-22. PMID 11458208 DOI: 10.1067/Mhn.2001.116187 | 0.367 | |||
| 2001 | Pogány G, Timár F, Oláh J, Harisi R, Polony G, Paku S, Bocsi J, Jeney A, Laurie GW. Role of the basement membrane in tumor cell dormancy and cytotoxic resistance. Oncology. 60: 274-81. PMID 11340380 DOI: 10.1159/000055329 | 0.363 | |||
| 2001 | Rásó E, Tóvári J, Tóth K, Paku S, Trikha M, Honn K, Tímár J. Ectopic αIIbβ3 Integrin Signaling Involves 12-Lipoxygenaseand PKC-mediated Serine Phosphorylation Events in Melanoma Cells Thrombosis and Haemostasis. 85: 1037-1042. DOI: 10.1055/S-0037-1615960 | 0.35 | |||
| 2000 | Tôkés A, Paku S, Tóth S, Paál E, Kulka J, Tóth J, Telekes A. Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures. Pathology & Oncology Research. 6: 202-209. PMID 11033461 DOI: 10.1007/Bf03032374 | 0.334 | |||
| 2000 | Sebestyén A, Tótth A, Mihalik R, Szakács O, Paku S, Kopper L. Syndecan-1-dependent homotypic cell adhesion in HT58 lymphoma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 21: 349-57. PMID 11006575 DOI: 10.1159/000030140 | 0.348 | |||
| 2000 | Hidvégi M, Rásó E, Tömösközi-Farkas R, Szende B, Paku S, Prónai L, Bocsi J, Lapis K. MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer Biotherapy & Radiopharmaceuticals. 14: 277-89. PMID 10850313 DOI: 10.1089/Cbr.1999.14.277 | 0.303 | |||
| 1999 | Sebestyén A, Berczi L, Mihalik R, Paku S, Matolcsy A, Kopper L. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. British Journal of Haematology. 104: 412-9. PMID 10050727 DOI: 10.1046/J.1365-2141.1999.01211.X | 0.302 | |||
| 1999 | Timar J, Raso E, Paku S, Kopper L. Oral administration of a trace element preparation and zinc inhibit liver metastasis of 3LL-HH murine tumor cells. International Journal of Molecular Medicine. 2: 105-8. PMID 9854152 DOI: 10.3892/Ijmm.2.1.105 | 0.37 | |||
| 1998 | Silletti S, Paku S, Raz A. Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells. International Journal of Cancer. 76: 129-135. PMID 9533772 DOI: 10.1002/(Sici)1097-0215(19980330)76:1<129::Aid-Ijc20>3.0.Co;2-6 | 0.359 | |||
| 1998 | Silletti S, Paku S, Raz A. Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization International Journal of Cancer. 76: 120-128. PMID 9533771 DOI: 10.1002/(Sici)1097-0215(19980330)76:1<120::Aid-Ijc19>3.0.Co;2-G | 0.357 | |||
| 1997 | Silletti S, Paku S, Raz A. Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines. Pathology & Oncology Research. 3: 230-254. PMID 18470736 DOI: 10.1007/Bf02899927 | 0.403 | |||
| 1997 | Kovalszky, Nagy JO, Gallai M, Sebestyén A, Schaff Z, Paku S, Jeney A, Iozzo RV. Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis. Pathology Oncology Research : Por. 3: 51-58. PMID 11173626 DOI: 10.1007/Bf02893354 | 0.374 | |||
| 1997 | Tóvári J, Paku S, Rásó E, Pogány G, Kovalszky I, Ladányi A, Lapis K, Tímár J. Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation. International Journal of Cancer. 71: 825-31. PMID 9180152 DOI: 10.1002/(Sici)1097-0215(19970529)71:5<825::Aid-Ijc21>3.0.Co;2-5 | 0.381 | |||
| 1996 | Tímár J, Tóvári J, Pogány G, Ladányi A, Paku S, Rśó E, Bocsi J, Jeney A, Lapis K. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells. European Journal of Cancer (Oxford, England : 1990). 152-9. PMID 8695225 DOI: 10.1016/0959-8049(95)00544-7 | 0.406 | |||
| 1990 | Lapis K, Pápay J, Paku S. Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice. Oncology. 47: 359-364. PMID 2367062 DOI: 10.1159/000226848 | 0.37 | |||
| 1990 | Paku S, Timár J, Lapis K. Ultrastructure of invasion in different tissue types by lewis lung tumour variants Virchows Archiv. 417: 435-442. PMID 2122587 DOI: 10.1007/Bf01606032 | 0.367 | |||
| 1989 | Paku S, Rot A, Ladányi A, Lapis K. Demonstration of the organ preference of liver selected 'high metastatic' Lewis lung tumor cell line. Clinical & Experimental Metastasis. 7: 599-607. PMID 2776366 DOI: 10.1007/Bf01753671 | 0.424 | |||
| 1986 | Vajta G, Divald A, Paku S, Elek J, Lapis K. Fatty degeneration in cultured hepatocytes. A new experimental model. Virchows Archiv B Cell Pathology Including Molecular Pathology. 52: 177-184. PMID 2878533 DOI: 10.1007/Bf02889961 | 0.311 | |||
| Show low-probability matches. | |||||